Novartis is investing in expanding Pluvicto's label into pre-taxane prostate cancer (SPLASH trial submission pending), and developing next-generation RLT approaches targeting breast cancer and other tumour types positioning it to maintain leadership in the highest-growth oncology peptide segment
Dias S, Welton NJ, Sutton AJ, Valdwell DM, Guobing L, Ades AE NICE DSU technical support document 4: inconsistency in networks of evidence based on randomised controlled trials
Claire is great, went to her for some peptide therapy and her knowledge is outstanding
Katz, M.D., a specialist in internal medicine with expertise in nutrition
Makeup (April 2023 to March 2024) Makeup trends Rising searches for electric makeup brush cleaners reflects a growing interest for convenience when it comes to beauty hygiene